RepliCel Life Sciences Inc.
RP
Ранг среди акций
#38675
Headquartered in Vancouver, Canada, RepliCel Life Sciences Inc. is a... Headquartered in Vancouver, Canada, RepliCel Life Sciences Inc. is a regenerative medicine company dedicated to developing innovative autologous cell therapies. These treatments are designed to correct functional cellular deficiencies by harnessing a patient's own cells. The process involves isolating cells from harvested tissues, significantly expanding them in a controlled laboratory environment, and subsequently applying them therapeutically. The company's developmental portfolio includes several key product candidates: RCT-01 targets chronic tendinosis, RCS-01 addresses aging and sun-damaged skin, and RCH-01 is aimed at treating hair loss. Additionally, RepliCel is advancing RCI-02, a specialized dermal injection device. RepliCel has established significant strategic alliances. It holds a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. to establish a clinical research program and facilitate the commercialization of RCS-01 and RCT-01. A similar collaboration exists with Shiseido Company, Limited, focusing on the clinical research program for RCH-01. Furthermore, the company is engaged in a research project agreement with the University of British Columbia, contributing to the creation of a comprehensive hair follicle cell data map.
Цена акции
$0.01100905
Последняя синхронизация: 2025-02-28
Рыночная капитализация
$810.02K
Изменение (1 день)
58.98%
Изменение (1 год)
10,909.05%
Страна
CA
Торговля RepliCel Life Sciences Inc. (RP)
Категория
Healthcare
Прибыль RepliCel Life Sciences Inc. (RP)
Прибыль на 2026 TTM: 0
Согласно последним финансовым отчетам RepliCel Life Sciences Inc., текущая прибыль компании составляет 0. В 2026 году компания получила прибыль 0, равна прибыли за 2026, которая составила 0. Отображаемая прибыль на этой странице — это прибыль до уплаты процентов и налогов, или просто EBIT.
История прибыли компании RepliCel Life Sciences Inc. с 2026 по 2026
Прибыль в конце каждого года
| Год | Прибыль | Изменить |
|---|---|---|
| Недостаточно данных для указанных дат. | ||
Прибыль схожих компаний или конкурентов
| Компания | Прибыль | Разница в прибыли | Страна |
|---|---|---|---|
| $5.27B | - |
US
|
|
| $-3.09B | - |
US
|
|
| $-4.02B | - |
AU
|
|
| - | - |
CH
|
|
| $1.95B | - |
NL
|
